GH/Omr |
diastolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
serial mean |
129.5 |
mmHg |
3.27 |
15.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
0 |
microrenathane catheter; recover for 1 week after surgery |
|
11523 |
101 |
GH/Omr |
heart left ventricle weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
21 |
|
4.7 |
mg/g |
0.15 |
0.7 |
post excision weight measurement |
|
0.0 |
0 |
ng/kg/min |
Original CMO ID was CMO:0000540. Corrected 2-15-2018. |
68334 |
101 |
GH/Omr |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127 days-143 days |
21 |
serial mean |
365.0 |
beats/min |
5.02 |
23.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
0 |
microrenathane catheter; recover for 1 week after surgery |
|
11524 |
101 |
GH/Omr |
mean arterial blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
serial mean |
155.7 |
mmHg |
3.06 |
14.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
0 |
microrenathane catheter; recover for 1 week after surgery |
|
11521 |
101 |
GH/Omr |
single kidney wet weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
kidney mass |
male |
132 days-146 days |
21 |
|
3.4 |
g/kg |
0.04 |
0.2 |
post excision weight measurement |
|
|
0 |
ng/kg/min |
kidney wet weight to body weight ratio (CMO:0003389) |
11526 |
101 |
GH/Omr |
mean arterial blood pressure |
controlled sodium chloride content diet (0.4 %) (for 3 days) then controlled sodium chloride content diet (4 %) (for 23 days) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
155 days-169 days |
20 |
serial mean |
147.5 |
mmHg |
2.06 |
9.2 |
radiotelemetry |
left femoral artery |
10 seconds every two minutes for 4 hrs/day every other day for 23 days |
0 |
Dataquest IV system; anesthetized by 1% isoflurane, recover for 3 days |
|
11556 |
101 |
GH/Omr |
heart left ventricle wet weight |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
21 |
|
1.69 |
g |
0.03 |
0.13 |
post excision weight measurement |
|
0.0 |
0 |
ng/kg/min |
|
68329 |
101 |
GH/Omr |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
14 |
|
-0.87 |
(beats/min)/(ug/kg) |
0.07 |
0.25 |
vascular indwelling catheter method |
|
0.0 |
0 |
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
138468 |
101 |
GH/Omr |
kidney wet weight |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
kidney mass |
male |
132 days-146 days |
21 |
|
1.22 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
|
0 |
ng/kg/min |
|
11525 |
101 |
GH/Omr |
body weight |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
body mass |
male |
132 days-146 days |
21 |
|
365.4 |
g |
3.71 |
17.0 |
body weighing method |
|
|
0 |
|
|
11527 |
101 |
GH/Omr |
systolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
serial mean |
190.9 |
mmHg |
2.12 |
9.7 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
0 |
microrenathane catheter; recover for 1 week after surgery |
|
11522 |
101 |
GH/Omr |
change in mean arterial blood pressure to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
130 days-144 days |
14 |
|
0.48 |
mmHg/ng/kg/min |
0.02 |
0.08 |
vascular indwelling catheter method |
left femoral artery and vein |
0.0 |
0 |
microrenathane catheter; recover for 1 week after surgery |
slope of map response curve |
68339 |
101 |